Browsing "1. Journal Papers" by Issue Date :
Showing results 1 to 20 of 1649
This table browses all dspace content
Issue Date | Title | Journal Title |
2025 | PM exposure during pregnancy affects childhood asthma via placental epigenetic changes: Neuronal differentiation and proliferation and Notch signaling pathways | ENVIRONMENTAL POLLUTION |
2024 | Pregnancy outcomes of cerclage in twin gestations: a multicenter retrospective cohort study
| JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE |
2024 | Oral hormone replacement therapy and uterine volume in Korean adolescents with Turner syndrome: A retrospective case-control study | JOURNAL OF PEDIATRIC AND ADOLESCENT GYNECOLOGY |
2024 | Factors affecting the technical outcome of catheter-directed sclerotherapy for ovarian endometriomas | EUROPEAN JOURNAL OF RADIOLOGY |
2024 | Decision-making process for risk-reducing salpingo-oophorectomy among Korean women with hereditary breast cancer: A grounded theory study | EUROPEAN JOURNAL OF ONCOLOGY NURSING |
2024 | Prognostic impact of intraoperative rupture in early-stage epithelial ovarian cancer: an ancillary study of GORILLA-3002 | EJSO |
2024 | Investigation of cell-to-cell transfer of polystyrene microplastics through extracellular vesicle-mediated communication | BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS |
2024 | Chemotherapy response score no longer predicts survival outcomes in high-grade serous ovarian cancer patients with BRCA mutation and/or maintenance therapy | JOURNAL OF GYNECOLOGIC ONCOLOGY |
2024 | Efficacy of large language models and their potential in Obstetrics and Gynecology education
| Obstetrics & Gynecology Science |
2024 | Prenatal Diagnosis and Clinical Outcomes of Isolated Mega Cisterna Magna | JOURNAL OF CHILD NEUROLOGY |
2024 | From the Beginning of the Korean Gynecologic Oncology Group to the Present and Next Steps
| CANCERS |
2024 | Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 trial | LANCET |
2024 | Impacts of Tocolytics on Maternal and Neonatal Glucose Levels in Women With Gestational Diabetes Mellitus
| JOURNAL OF KOREAN MEDICAL SCIENCE |
2024 | Commentary: Thoracic Endometriosis: The Necessity of a Multidisciplinary Approach for Optimal Treatment | Journal of Chest Surgery |
2024 | Anti-4-1BB×PDL1 Bispecific Antibody Reinvigorates Tumor-Specific Exhausted CD8+ T Cells and Enhances the Efficacy of Anti-PD1 Blockade | CLINICAL CANCER RESEARCH |
2024 | Therapeutic effects of surgical debulking of metastatic lymph nodes in cervical cancer IIICr: a trial protocol for a phase III, multicenter, randomized controlled study (KGOG1047/DEBULK trial)
| JOURNAL OF GYNECOLOGIC ONCOLOGY |
2024 | Effects of subcutaneous drain on wound dehiscence and infection in gynecological midline laparotomy: Secondary analysis of a Korean Gynecologic Oncology Group study (KGOG 4001) | EJSO |
2024 | Pembrolizumab or Placebo With Chemoradiotherapy Followed by Pembrolizumab or Placebo for Newly Diagnosed, High-Risk, Locally Advanced Cervical Cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): A Randomized, Double-Blind, Phase 3 Clinical Trial | OBSTETRICAL & GYNECOLOGICAL SURVEY |
2024 | GX-188E DNA vaccine plus pembrolizumab in HPV 16- and/or 18-positive recurrent or advance cervical cancer: a phase 2 trial | ECLINICALMEDICINE |
2024 | Particulate matter exposure induces adverse effects on endometrium and fertility via aberrant inflammatory and apoptotic pathways in vitro and in vivo | CHEMOSPHERE |